Merck & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Hold
93,414
0.61% 9
2025
Q1
$1.26M Hold
93,414
0.77% 9
2024
Q4
$1.79M Buy
+93,414
New +$1.79M 0.69% 8